Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Swartz

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
Biochemical and Biophysical Research Communications|October 15, 2009
Multiply mutated Gaussia luciferases provide prolonged and intense bioluminescenceJohn P Welsh, Kedar G Patel, Karthish Manthiram, et al.
Journal of Bacteriology|November 26, 2008
Continued protein synthesis at low [ATP] and [GTP] enables cell adaptation during energy limitationMichael C Jewett, Mark L Miller, Yvonne Chen, et al.
The Journal of Biological Chemistry|July 21, 2016
Characterization of [FeFe] Hydrogenase O2 Sensitivity Using a New, Physiological ApproachJamin Koo, Stacey Shiigi, Marcus Rohovie, et al.
Metabolic Engineering|June 17, 2008
Cell-free metabolic engineering promotes high-level production of bioactive Gaussia princeps luciferaseAaron R Goerke, Andreas M Loening, Sanjiv S Gambhir, et al.
Angewandte Chemie (International Ed. in English)|December 16, 2016
High-Throughput Screening of Catalytic H<sub>2</sub> ProductionJamin Koo, Tim Schnabel, Sylvie Liong, et al.
Biotechnology Progress|January 26, 2012
Simplifying and streamlining Escherichia coli-based cell-free protein synthesisWilliam C Yang, Kedar G Patel, H Edward Wong, et al.
Iscience|June 11, 2025
Multifunctional nanoparticle platform for targeted delivery and vaccinesAnja S Redecker, Medea Neek, Philip E J Smith, et al.
Protein Expression and Purification|September 21, 2010
Escherichia coli-based production of a tumor idiotype antibody fragment--tetanus toxin fragment C fusion protein vaccine for B cell lymphomaKedar G Patel, Patrick P Ng, Shoshana Levy, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2015
Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug deliveryYuan Lu, Wei Chan, Benjamin Y Ko, et al.
Blood|December 14, 2006
Cell-free production of scFv fusion proteins: an efficient approach for personalized lymphoma vaccinesGregory Kanter, Junhao Yang, Alexei Voloshin, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Biochemical and Biophysical Research Communications|October 15, 2009
Multiply mutated Gaussia luciferases provide prolonged and intense bioluminescenceJohn P Welsh, Kedar G Patel, Karthish Manthiram, et al.
Journal of Bacteriology|November 26, 2008
Continued protein synthesis at low [ATP] and [GTP] enables cell adaptation during energy limitationMichael C Jewett, Mark L Miller, Yvonne Chen, et al.
The Journal of Biological Chemistry|July 21, 2016
Characterization of [FeFe] Hydrogenase O2 Sensitivity Using a New, Physiological ApproachJamin Koo, Stacey Shiigi, Marcus Rohovie, et al.
Metabolic Engineering|June 17, 2008
Cell-free metabolic engineering promotes high-level production of bioactive Gaussia princeps luciferaseAaron R Goerke, Andreas M Loening, Sanjiv S Gambhir, et al.
Angewandte Chemie (International Ed. in English)|December 16, 2016
High-Throughput Screening of Catalytic H<sub>2</sub> ProductionJamin Koo, Tim Schnabel, Sylvie Liong, et al.
Biotechnology Progress|January 26, 2012
Simplifying and streamlining Escherichia coli-based cell-free protein synthesisWilliam C Yang, Kedar G Patel, H Edward Wong, et al.
Iscience|June 11, 2025
Multifunctional nanoparticle platform for targeted delivery and vaccinesAnja S Redecker, Medea Neek, Philip E J Smith, et al.
Protein Expression and Purification|September 21, 2010
Escherichia coli-based production of a tumor idiotype antibody fragment--tetanus toxin fragment C fusion protein vaccine for B cell lymphomaKedar G Patel, Patrick P Ng, Shoshana Levy, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2015
Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug deliveryYuan Lu, Wei Chan, Benjamin Y Ko, et al.
Blood|December 14, 2006
Cell-free production of scFv fusion proteins: an efficient approach for personalized lymphoma vaccinesGregory Kanter, Junhao Yang, Alexei Voloshin, et al.
Pageof 9